Deferiprone 600mg delayed release tablets: Clinical Trials

1 trial of Deferiprone 600mg delayed release tablets, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Completed 1

Follow Deferiprone 600mg delayed release tablets: new trials by email Literature Review of Deferiprone 600mg delayed release tablets trials Research Report on Deferiprone 600mg delayed release tablets

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Deferiprone to Delay Dementia (The 3D Study)
Deferiprone 600mg delayed release tablets, Placebo Oral Tablet - Mild Cognitive Impairment, Prodromal Alzheimer's Disease
Phase 2CompletedNeuroscience Trials Australia812018-01-192024-07-03

Conditions studied

Alzheimer Disease (1)  ·  Cognitive Dysfunction (1)  ·  Dementia (1)

Sponsors

Neuroscience Trials Australia (1)

Countries

Australia (1)

Top investigators

Ashley I. Bush (1)

Results publications

PMID 39495531